成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> International Journal of Phytopharmacy >>article

International Journal of Phytopharmacy

Download PDF

Teneligliptin: DPP-4 inhibitor in the treatment of type II Diabetes Mellitus

Published:30 August 2017 DOI: 10.7439/IJPP.V7I4.4347
K. Danao, M. Shende, Rohit A. Gupta, Nitin G Dumore, U. Mahajan

Abstract

The collective review of teneligliptin as an antidibetic drug concerning about the mechanisms of action, pharmacokinetic study, pharmacodynamic study, toxicological study and dose and its contraindication. Teneligliptin is used in the treatment of type II diabetes mellitus. Teneligliptin, a third generation DPP-4 inhibitor, teneligliptin was approved by the US Food and Drug Administration on 2012 based on a large development program. Teneligliptin, a novel DPP-4 inhibitor, exhibits a unique structure characterized by five consecutive rings, which produce a potent and long-lasting effect. Teneligliptin is currently used in cases showing insufficient improvement in glycemic control even after diet control and exercise or a combination of diet control, exercise, and sulfonylurea or thiazolidine-class drugs. In adults, teneligliptin is orally administered at a dosage of 20 mg once daily, which can be increased up to 40 mg per day. Due to the metabolites of this drug are eliminated via renal and hepatic excretion so, adjustable dose is not required to renal impairment patient. In this review, all the clinical data is described. Teneligliptin shows promise in stabilizing glycemic fluctuations throughout the day and consequently suppressing the progression of diabetic complications.

Substances (4)

Related products
Procduct Name CAS Molecular Formula Supplier Price
THIAZOLIDINE 504-78-9 C3H7NS 262 suppliers $16.00-$930.18
Teneligliptin 760937-92-6 C22H30N6OS 187 suppliers $45.00-$959.70
CAY10535 Exclusive 945716-28-9 C18H21N3O7S 9 suppliers $36.00-$1801.00
TRELAGLIPTIN(SYR-472) is a long-acting DPP-4 inhibitor. 3 suppliers Inquiry

Similar articles

IF:1.3

Teneligliptin: Heralding Change in Type 2 Diabetes

Journal of Database Management M. Maladkar,?Srividya Sankar,etc Published: 31 March 2016
IF:13

Linagliptin: in type 2 diabetes mellitus.

Drugs Lesley J Scott,etc Published: 26 March 2011
IF:13

Dapagliflozin: a review of its use in type 2 diabetes mellitus.

Drugs Greg L Plosker,etc Published: 3 December 2012